Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1375468-12-4

Post Buying Request

1375468-12-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1375468-12-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1375468-12-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,5,4,6 and 8 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1375468-12:
(9*1)+(8*3)+(7*7)+(6*5)+(5*4)+(4*6)+(3*8)+(2*1)+(1*2)=184
184 % 10 = 4
So 1375468-12-4 is a valid CAS Registry Number.

1375468-12-4Relevant articles and documents

Coupling the near-infrared fluorescent dye IR-780 with cabazitaxel makes renal cell carcinoma chemotherapy possible

Zheng, Yu,Lan, Ting,Wei, Di,Zhang, Geng,Hou, Guangdong,Yuan, Jiarui,Yan, Fei,Wang, Fuli,Meng, Ping,Yang, Xiaojian,Chen, Guo,Zhu, Zheng,Lu, Zifan,He, Wei,Yuan, Jianlin

, (2019)

Renal cell carcinoma (RCC) has always been considered resistant to chemotherapy. IR-780 is a near-infrared fluorescent (NIRF) dye that can be efficiently taken up by RCC cells. Cabazitaxel is a cytotoxic drug that interferes with mitosis by acting on tubu

Polymeric conjugates of active principles, their process of preparation and their polymeric intermediates

-

Page/Page column 17-18, (2016/06/01)

The present invention relates to novel conjugates of active principles grafted to a polymer, to the nanoparticles comprising them, to their preparation and to their polymeric intermediates.

Targeted Conjugates Encapsulated in Particles and Formulations Thereof

-

Paragraph 0270; 0271, (2014/07/08)

Particles, including nanoparticles and microparticles, and pharmaceutical formulations thereof, containing conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to a targeting moiety via a linker have been designed which can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the conjugates, the particles, and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided, for example, to treat or prevent cancer or infectious diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1375468-12-4